Media Coverage
Read how Vistagen’s intention to revolutionize mental health medicine is causing a buzz in the media.
The Biotech Project: Featuring Shawn Singh
Combatting the Mental Health Crisis with an Acute Treatment Nasal Spray
UPDATE: VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety
Diversity Drives Better Outcomes
New Social Anxiety Disorder Drug Differentiates Mechanism of Action
Expert: There is a Dire Need to Improve, More Effectively Treat Mental Health Disorders for Returning Veterans
This Drug Has the Potential to Become the First FDA-Approved on-Demand Treatment for Social Anxiety
Psychiatric drugs were once a $30 billion business. Analysts say these 9 companies could revive it.
BioSpace Movers & Shakers, May 7
